Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

FOS 2 > Pharmacology > Flashcards

Pharmacology Flashcards

1
Q

Occupation of a receptor by a drug always results in acitvation of the receptor.

True or false.

A

False - it may or may not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is receptor activation?

A

It means that the receptor is affected by the bound molecule in such a way as to elicit a tissue response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Distinguish between binding and activation.

A

Binding of ligand to receptor does not always result in activation. Binding and activation represent two distinct steps in the generation of receptor mediated tissue response by an agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an antagonist?

A

Something that binds to the receptor without causing activation of the receptor and thereby prevents an agonist from binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is potency?

How is this depicted on a dose-response curve?

A

A measure of the amount of drug necessary to cause a biological effect

By the [Drug] at 50% response. A drug with higher potency will reach 50% response with less [Drug].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is EC50?

A

The drug concentration that produces 50% of the maximum possible response in a graded dose-response curve. It is a measure of potency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is efficacy? What does it depend on?

How is this represented on a dose-response curve?

A

The ability of a drug to elicit a response when it interacts with a receptor. It is dependent on the number of drug-receptor complexes formed and the efficiency of coupling of receptor activation to cellular response.

The amount of response that is ellicited. If a drug reaches 100% response, it is 100% efficacious. If another drug reaches 80% response it is less efficacous than the drug that reached 100%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a partial agonist?

A

They have intermediate levels of efficacy such that even when 100% of the receptors are occupied the tissue response is submaximal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What 2 things influence potency?

A

Affinity and efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a competitive antagonist?

How is this displayed on a dose-response curve?

How are its effects overcome?

A

When both the agonist and antagonist bind to the same site on the receptor, they are said to be competitive. Competitive antagonists prevent an agonist from binding to its receptor and maintain the receptor in its inactive conformation.

Recognized by a righward shift of the graph. Slopes remain parallel and the agonist will always reach 100% response but will take longer.

Effects overcome by adding more agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is an irreversible antagonist?

Does adding more agonist overcome the effects of an irreversible antagonist?

What would the dose-response curve look like?

A

Causes a downward shift of the maximum response because they bind to the receptor permanently and make it so the receptor is no longer funtional.

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Competitive antagonism reduces an agonist’s ________

Irreversible antagonism reduces an agonist’s ________

A

Potency

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a quantal response?

What are they useful for determining?

A
  • A dose-response relationship that is of the influence of the magnitude of the dose on the proportion of a population that responds
  • Doses to which most of the population responds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the therapeutic index?

A

The ratio of a drug’s toxic dose to its therapeutic dose. A safe drug has a high therapeutic index.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What would a dose-response curve look like for a drug with a narrow therapeutic index?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What would a dose-response curve look like for a drug with a wider therapeutic index?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What 3 things affect how well a drug interacts with its receptor?

A

Size

Chirality

Shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Kd for a receptor?

A

The concentration of drug at which 50% of the receptors are bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Bmax for a receptor?

A

The maximal number of receptors bound. It is a measure of the amount of drug required to saturate a population of receptors and a measure of the number of receptors present in the sample.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does it mean if the EC50 < Kd for the receptor?

A

1) The duration of the activation of the effectory may be much greater than the duration of the drug-receptor interaction
2) The actual number of receptors may exceed the number of effector molecule available (spare receptors)

21
Q

Spare receptors increase the _____ to the agonist b/c the likelihood of drug-receptor inteaction increases in proportion to the number of receptors available.

A

Sensitivity

22
Q

What is the orthosteric site of a receptor?

What are allosteric sites of a receptor?

A

Where agonists and competitive antagonists bind

Where other drugs/molecules can bind to influence receptor function in various ways

23
Q

Describe the process of extracellular and intracellular densitization of ion channels.

A

Extracellular: A conformational change in the receptor results in tight binding of the agonist molecule without opening of the ion channel. This process is rapid and pronounced.

Intracellular: phosphorylation of intracellular regions is another means that can induce desensitization, but it is slower than extracellular route.

24
Q

Is binding of ligand to the receptor always required to activate the receptor?

A

Not always - there are some examples of receptors that have appreciable levels of activity when no ligand is bound - constitutively active.

25
Q

What is an inverse agonist?

A

A drug that reduces the level of constitutive activation of receptors.

26
Q

Most of the receptor antagonists in clinical use are actually _____?

A

Inverse agonists

27
Q

Chemical antagonism

A

Uncommon situation where two substances combine in solution and the effect of the active drug is lost

28
Q

Pharmacokinetic Antagonism

A

Situation where the antagonist reduces the concentration of the active drug at its site of action by either (1) increasing rate of degradation or (2) reducing the rate of absorption

29
Q

Non-competitive antagonism

How does the dose-response curve appear as a result?

A
  • Antagonist blocks a point downstream from the receptor, and affects the chain of events that leads to the response by the agonist
  • Slope and maximum of agonist are reduced, also possible to see rightwards shift
30
Q

Physiological antagonism

A

Interaction of 2 drugs whose opposing actions in the body cancel each other out

31
Q

What is a synonym for desensitization?

A

Tachyphylaxis

32
Q

Describe desensitization of GPCRs

A

Phosphorylation of intracellular component of GPCR interferes with ability to activate second messenger cascade. Termed uncoupling.

33
Q

Describe the affect of prolonged exposure to agonists.

A

A gradual decrease in the number of receptors expressed on the cell surface is seen as a result of internalization of the receptors. These internalized receptors are taken up by endocytosis of patches of the membrane due to receptor phosphorylation.

34
Q

What is receptor exhaustion?

A

When a receptor becomes desensitized due to depletion of an essential intermediate substance.

35
Q

How can the body adapt to a drug’s effects?

A

A drug’s effects may become lessened, possibly due to altered gene expression resulting in changes in the levels of various regulatory molecules but little known about the mechanisms involved.

36
Q

What are targets for drug binding?

A

Receptors

Enzymes

Carriers

Ion channels

37
Q

What is the pharmacological definition of a receptor?

A

A protein molecule whose function is to recognize and respond to endogenous chemical signals.

38
Q

What are the major types of bonds between drugs and receptors?

A

Covalent

Electrostatic

Hydrophobic

39
Q

Hydrophobic bonds are most important for interactions between highly lipid soluble drugs with what targets?

A

Lipids of cell membranes and internal walls of receptor pockets

40
Q

Drugs that bind to strong bonds to their receptors are generally more selective than drugs that bind by means of weak bonds.

True/False

A

False - drugs that bind via weak bonds are more selective. Although the bonds are weaker, the precision of the fit between the drug and its receptor must be much higher in order for that drug to still induce a response. As such, very few receptor types are likley to provide such a tight fit and generate effects.

41
Q

How does drug size affect drug-receptor interactions?

A

Drugs generally 100 - 1000 Daltons in size.

Lower limit sets requirement for specificity.

Upper limit sets requirement for movement throughout body (can’t be too large or won’t diffuse to tissues).

42
Q

How does chirality influence drug receptor interactions?

A

Most drugs are chiral molecules but in most cases one of the enantiomers that are possible is more potent than the other. Enzymes are usually stereoselective and tend to metabolize only a specific enantiomer of a drug –> duration of action of one enantiomer may be very different than that of the other.

43
Q
  • Histamine is formed from the amino acid _____ and exerts its effects on ________ located on cell surfaces.
  • Histamine is an _____ and a _______.
  • It regulates what physiologic pathways?
A
  • Histidine; GPCRs
  • Autacoid (acts like local hormone); neurotransmitter
  • Immune, slee/wake, vestibular system
44
Q
A
45
Q
  • Histamine signaling through H1 receptors ____ the permeability of capillaries.
  • Histamine signaling through H1 receptors ____ the sensory nerve endings that mediate pain and itching.
  • These signals what kind of response?
A
  • Increases
  • Stimulates
  • Immune –> fluid leaving capillaries leads to runny nose/watery eyes
46
Q

Histamine signaling through H1 receptors promotes the release of what 2 hormones in the CNS?

A

Epinephrine

Norepinephrine

47
Q

______ is an antagonist of all H1 receptors.

A

Diphenhydramine

48
Q

____ is an antagonist of only peripheral H1 receptors and it cannot cross the blood/brain barrier to enter the CNS.

A

Fexofenadine

49
Q

____ is an antagonist against all H2 receptors.

A

Cimetidine

FOS 2 (44 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions